Home About Archives RSS Feed

The Independent Investor: CBD Is a Real Market

By Bill Schmick
iBerkshires columnist
Cannabidiol is popping up all over the country. Local drug stores, supermarkets and health food shops, among other retailers, can't seem to get enough of this stuff on the shelves. Is this a fad, a fake, or does it have some real health benefits?
 
It's called CBD, for short, and this oil can be eaten, inhaled, and/or applied to the skin.  It is a substance extracted from the flowers and buds of the marijuana and hemp plant. And no, before you ask, you can't get high from it.  
 
Back in the day, (when I had hair to my shoulders, along with my buckskin jacket) I simply smoked marijuana or ate it in cookies. It contained THC. THC, a chemical, attaches to the CB1 receptors in the brain and triggers all those familiar sensations like increased appetite, giddiness, moods swings, etc.  Unlike THC, CBD was at first thought to attach to the CB2 receptors, which does not trigger psychoactive sensations. You don't get a buzz from it, although for someone like me that is no longer important.
 
The FDA allows CBD to be prescribed for epileptic seizure disorders and other ailments, but the research for other uses is till ongoing. Most consumers are using it for things like anti-inflammation and pain, especially for arthritis and injuries. Diabetes and acne are also conditions where CBD is used. Others believe it may have properties to treat Alzheimer's disease. Whether any of these claims are true, will be borne out in time through research.
 
Given my own arthritis issues, I decided not to wait to try it on my neck problems. It worked. The pain vanished for an entire day. I gave some to my neighbor, who has the same condition. It worked on him as well. Certainly, that is no scientific study, just personal experience. Now, what you should know is that CBD can be derived from both hemp and marijuana plants, which are similar, but not identical. Thanks to the Agricultural Improvement Act of 2018, hemp is now legal to grow and sell. Marijuana is not.  The CBD, which is derived from hemp is legal, as long as it contains less than 0.3 percent THC.
 
Sales of hemp-derived CBD oil four years ago was around $90 million. By next year, sales are estimated to top $450 million. If, over the next year or so, the federal government allows marijuana-derived CBD to be legally sold, the CBD market could generate as much as $1.2 billion in revenues.
 
CBD crystals are the purest form of the product. It can be dabbed, made into a tincture, or used as an edible by mixing it with high-fat foods. Topicals and salves can be sold as soap, lotions, even shampoos. It can be inhaled as a wax or inhaled as a vapor, as well as eaten in chocolates, baked goods, and even gummy bears. Pills and capsules are now marketed as nutritional supplements as well.
 
By the way, Titus, our ten-year-old Chocolate Lab, has been eating CBD-infused snacks for over two months now. Like me, Titus suffers from arthritis (me in the neck/back, him in both shoulders). Since he has many of the same brain receptors that I do, CBD works well on his arthritis as well
 
While pot stocks overall remain the darlings of the stock market, at least those companies that sell the legal form of CBD may have some real value. As for the companies that market the THC-based products, the risk is much higher. Under federal laws, growing and selling marijuana is not legal, at least until the U.S. government and more states pass new legislation that would legalize those products. That should happen within the next 12-18 months, according to both company managements as well as some legislators.
 
Bill Schmick is registered as an investment adviser representative and portfolio manager with Berkshire Money Management (BMM), managing over $400 million for investors in the Berkshires.  Bill's forecasts and opinions are purely his own. None of the information presented here should be construed as an endorsement of BMM or a solicitation to become a client of BMM. Direct inquiries to Bill at 1-888-232-6072 (toll free) or email him at Bill@afewdollarsmore.com.

 

0 Comments
     

Support Local News

We show up at hurricanes, budget meetings, high school games, accidents, fires and community events. We show up at celebrations and tragedies and everything in between. We show up so our readers can learn about pivotal events that affect their communities and their lives.

How important is local news to you? You can support independent, unbiased journalism and help iBerkshires grow for as a little as the cost of a cup of coffee a week.

News Headlines
PopCares Cancer Charity Has Helped Nearly 900 People
North Adams Airport Commission Finalizes Restaurant RFP
Pittsfield School Committee Concerned With Teacher Retention
Williams Women's Tennis Wraps Up Fall Campaign
Berkshire County Kids' Place Gala Celebrates Courage
Maimaron, Williams Football Cruise Past Bates
MCLA Women's Cross Country Competes at Western New England
Noted 'Edu-Tainer' Brings Message of Tolerance to Mount Greylock Educators
Wahconah Unveils Banner Marking National Unified Sports Honor
Northern Berkshire Coalition Forum Envisions 'Inclusive Development'

Bill Schmick is registered as an investment advisor representative and portfolio manager with Berkshire Money Management (BMM), managing over $200 million for investors in the Berkshires. Bill’s forecasts and opinions are purely his own and do not necessarily represent the views of BMM. None of his commentary is or should be considered investment advice. Anyone seeking individualized investment advice should contact a qualified investment adviser. None of the information presented in this article is intended to be and should not be construed as an endorsement of BMM or a solicitation to become a client of BMM. The reader should not assume that any strategies, or specific investments discussed are employed, bought, sold or held by BMM. Direct your inquiries to Bill at 1-888-232-6072 (toll free) or email him at Bill@afewdollarsmore.com Visit www.afewdollarsmore.com for more of Bill’s insights.

 

 

 



Categories:
@theMarket (305)
Independent Investor (416)
Archives:
October 2019 (6)
October 2018 (2)
September 2019 (7)
August 2019 (5)
July 2019 (5)
June 2019 (8)
May 2019 (10)
April 2019 (7)
March 2019 (7)
February 2019 (6)
January 2019 (6)
December 2018 (4)
November 2018 (9)
Tags:
Crisis Energy Markets Retirement Euro Metals Congress Deficit Currency Debt Economy Japan Pullback Jobs Debt Ceiling Commodities Stimulus Wall Street Europe Banks Interest Rates Rally Housing Stock Market Recession Fiscal Cliff Oil Election Taxes Bailout Stocks Europe Selloff Federal Reserve Greece
Popular Entries:
The Independent Investor: Don't Fight the Fed
@theMarket: QE II Supports the Markets
The Independent Investor: Understanding the Foreclosure Scandal
The Independent Investor: Does Cash Mean Currencies?
@theMarket: Markets Are Going Higher
The Independent Investor: General Motors — Back to the Future
@theMarket: Economy Sputters, Stocks Stutter
The Independent Investor: How Will Wall Street II Play on Main Street?
The Independent Investor: Why Are Interest Rates Rising?
The Independent Investor: Will the Municipal Bond Massacre Continue?
Recent Entries:
@theMarket: Markets Await a Brexit Vote
The Independent Investor: Was There Really a Trade Deal?
@theMarket: Stocks Soar on 'Skinny' Deal
The Independent Investor: Brokerage Business Not What It Used to Be
@theMarket: An October to Remember
The Independent Investor: Markets Bogged Down by Politics
@theMarkets: Markets Muddle Through
The Independent Investor: India's Bid for More Trade
The Independent Investor: The Era of U.S. Oil Independence
@theMarket: Investors Discover Value Stocks